Master Allergen Child Nutrition. Reintroduction of Small Doses

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Reintroduction of small doses of food in allergic children to lightening the elimination diet.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy

NCT05080127

Food Allergy Quality of Life

UNKNOWN NA

Assessment of Orality Disorders in Children With Food Allergies

NCT04378335

Food Allergy in Children 6 Years Old Maximum

COMPLETED NA

Relevance of Sensitization to Legumes in Children Allergic to Peanut

NCT04329078

Allergy;Food

UNKNOWN

Impact of the Therapeutic Education on the Quality of Life of the Child Suffering of Food Allergy IgE-mediated

NCT02106169

IgE Mediated Food Allergy

COMPLETED NA

Evaluation of The Food Allergy Mastery Program

NCT06034678

Food Allergy in Children

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In four groups of allergic children (peanuts, wheat , milk and egg), a reintroduction of 4 small increasing doses of allergen is carried out progressively double-blind placebo- cons , randomized, during a hospitalization.

The procedure for reintroduction of small doses (MPD) is stopped at the appearance of intolerance (in taking a dose of allergen or placebo) defined by the onset of allergic symptoms or objective severe abdominal pain within 45 minutes of taking.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Food Allergies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

allergic food

Reintroduction procedure for small doses :

* Administration of the first dose the first dose must be allergic food or placebo
* Clinical monitoring for 45 minutes
* Administration of the second dose

Group Type EXPERIMENTAL

allegic food

Intervention Type OTHER

Reintroduction procedure for small doses :

* Administration of the first dose
* Clinical monitoring for 45 minutes
* Administration of the second dose

Placebo

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

allegic food

Reintroduction procedure for small doses :

* Administration of the first dose
* Clinical monitoring for 45 minutes
* Administration of the second dose

Intervention Type OTHER

Placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Allergic children 1 and 16 years for peanut, egg and wheat. So, for milk between 9 months and 16 years.
* Accurate diagnostic
* Allergic react rapidly and acute